C12N 2501/2303
Interleukin-3
Official title: Interleukin-3 (IL-3)
C12N2501/2303 (Interleukin-3) appears on 164 US grants and 414 published applications in this corpus.
Search patents in C12N- Granted patents
- 164
- Published applications
- 414
- Assignees
- 223
- Inventors
- 769
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 4 |
| 2006 | 0 | 1 |
| 2007 | 0 | 5 |
| 2008 | 1 | 2 |
| 2009 | 1 | 2 |
| 2010 | 3 | 2 |
| 2011 | 2 | 3 |
| 2012 | 2 | 9 |
| 2013 | 2 | 14 |
| 2014 | 6 | 11 |
| 2015 | 9 | 16 |
| 2016 | 12 | 19 |
| 2017 | 8 | 15 |
| 2018 | 6 | 23 |
| 2019 | 10 | 24 |
| 2020 | 12 | 35 |
| 2021 | 7 | 36 |
| 2022 | 10 | 44 |
| 2023 | 16 | 31 |
| 2024 | 17 | 39 |
| 2025 | 23 | 29 |
| 2026 | 13 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of culturing quiescent hematopoietic stem cells and treatment methods6 Oct 2026US 12,753,389 B2Icahn School of Medicine at Mount Sinai
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- CRISPR compositions and methods for promoting gene editing of ribosomal protein S19 (RPS19) gene4 Aug 2026US 12,698,513 B2EmendoBio Inc.
- And efficient method for reprogramming blood to induced pluripotent stem cells14 Jul 2026US 12,680,082 B2Cedars-Sinai Medical Center
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- T cell progenitor production method1 Oct 2026US 2026/0297522 A1Kyoto University
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Patient specific induced pluripotent stem cell derived macrophages for cell based therapy24 Sep 2026US 2026/0284107 A1Board of Regents, The University of Texas System
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
Most cited
By later US patents
- Method of reconstituting human lymphoid and dendritic cells38US 6,015,554 ASystemix, Inc. · 2000
- Methods of generating natural killer cells23US 8,926,964 B2Anthrogenesis Corporation · 2015
- Generation of induced pluripotent stem cells from small volumes of peripheral blood21US 9,447,382 B2Cellular Dynamics International, Inc. · 2016
- In vitro production of red blood cells with proteins comprising sortase recognition motifs17US 10,471,099 B2Whitehead Institute for Biomedical Research · 2019
- Methods and compositions for inducing hematopoietic cell differentiation17US 10,626,372 B1Fate Therapeutics, Inc. · 2020